1. Peiris JS, Yuen KY, Osterhaus AD and Stöhr K. The severe acute respiratory syndrome. New England Journal of Medicine. 2003; 349(25): 2431-41. DOI: 10.1056/NEJMra032498
2. Mijović B. COVID-19: Lessons learned. Scripta Medica. 2020; 51(1): 1-5. DOI: 10.5937/scriptamed51-25824
3. Rothan HA and Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of autoimmunity. 2020; 109(102433). DOI: 10.1016/j.jaut.2020.102433
4. Sarkarat F, Tootoonchian A, Haraji A, Rastegarmoghaddam Shaldoozi H, Mostafavi M and Naghibi Sistani SMM. Evaluation of dentistry staff involvement with COVID-19 in the first 3 month of epidemiologic spreading in Iran. journal of research in dental sciences. 2020; 17(2): 137-45. DOI: 10.29252/jrds.17.2.137 [In Persian]
5. Wang C, Horby PW, Hayden FG and Gao GF. A novel coronavirus outbreak of global health concern. The lancet. 2020; 395(10223): 470-3. DOI:https://doi.org/10.1016/S0140-6736(20)30185-9
6. Ahmadikia K, Mahmoudi S, Hassanali F, Keshavarz M, Mirhendi H and Malekzadeh E. A Review on the diagnostic approaches of COVID-19 infection; Features and limitations. Journal of Isfahan Medical School. 2021; 39(611): . DOI: 10.22122/jims.v39i611.13023 [In Persian]
7. Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, Yu J, Kang M, Song Y and Xia J. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. New England Journal of Medicine. 2020; 382(12): 1177-9. DOI: 10.1056/NEJMc2001737
8. Gholipour S, Shamsizadeh Z, Moazeni M and Nikaeen M. Environmental aspects of the coronaviruses transmission: A narrative review. Journal of Isfahan Medical School. 2020; 38(570): . DOI: 10.22122/jims.v38i570.12893 [In Persian]
9. Tré-Hardy M, Blairon L, Wilmet A, Beukinga I, Malonne H, Dogné J-M and Douxfils J. The role of serology for COVID-19 control: Population, kinetics and test performance do matter. The Journal of infection. 2020; 81(2): e91-e2. DOI: 10.1016/j.jinf.2020.05.019
10. Cai X-f, Chen J, li Hu J-, Long Q-x, Deng H-j, Liu P, Fan K, Liao P, Liu B-z and Wu G-c. A peptide-based magnetic chemiluminescence enzyme immunoassay for serological diagnosis of coronavirus disease 2019. The Journal of infectious diseases. 2020; 222(2): 189-93. DOI: 10.1093/infdis/jiaa243
11. Mehrian P and Farnia P. The role of computerized tomography scan in diagnosis and management of coronavirus disease 2019 (COVID-19). Journal of Isfahan Medical School. 2020; 38(578): . DOI: 10.22122/jims.v38i578.13080 [In Persian]
12. Gad M, Kazibwe J, Quirk E, Gheorghe A, Homan Z and Bricknell M. Civil-military cooperation in the early response to the COVID-19 pandemic in six European countries. 2021; 167(4): 234-43. DOI:10.1136/bmjmilitary-2020-001721
13. Farnoosh G, Alishiri G, Hosseini Zijoud S, Dorostkar R and Jalali Farahani A. Understanding the 2019-novel coronavirus (2019-nCoV) and coronavirus disease (COVID-19) based on available evidence-a narrative review. J Mil Med. 2020; 22(1): 1-11. DOI: 10.30491/JMM.22.1.1 [In Persian]
14. Poustchi H, Darvishian M, Mohammadi Z, Shayanrad A, Delavari A, Bahadorimonfared A, Eslami S, Javanmard SH, Shakiba E and Somi MH. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study. The Lancet Infectious Diseases. 2021; 21(4): 473-81. DOI: 10.1016/S1473-3099(20)30858-6
15. Nikpouraghdam M, Farahani AJ, Alishiri G, Heydari S, Ebrahimnia M, Samadinia H, Sepandi M, Jafari NJ, Izadi M and Qazvini A. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study. Journal of Clinical Virology. 2020; 127(104378). DOI: 10.1016/j.jcv.2020.104378
16. Ghafari M, Kadivar A and Katzourakis A. Excess deaths associated with the Iranian COVID-19 epidemic: A province-level analysis. Int J Infect Dis. 2021; 107(101-15). https://doi.org/10.1016/j.ijid.2021.04.015
17. Shakiba M, Nazemipour M, Heidarzadeh A and Mansournia MA. Prevalence of asymptomatic COVID-19 infection using a seroepidemiological survey. Epidemiology and Infection. 2020; 148(e300). DOI: 10.1017/S0950268820002745
18. Ceylan Z. Estimation of COVID-19 prevalence in Italy, Spain, and France. Science of The Total Environment. 2020; 729(138817). https://doi.org/10.1016/j.scitotenv.2020.138817
19. Farnoosh G, Ghanei M, Khorramdelazad H, Alishiri G, Farahani AJ, Shahriary A and Zijoud SRH. Are Iranian sulfur mustard gas-exposed survivors more vulnerable to SARS-CoV-2? Some similarity in their pathogenesis. Disaster medicine and public health preparedness. 2020; 14(6): 826-32. DOI: 10.1017/dmp.2020.156.
20. Xie Y, Wang X, Yang P and Zhang S. COVID-19 complicated by acute pulmonary embolism. Radiology: Cardiothoracic Imaging. 2020; 2(2): e200067. https://doi.org/10.1148/ryct.2020200067
21. Casey K, Iteen A, Nicolini R and Auten J. COVID-19 pneumonia with hemoptysis: acute segmental pulmonary emboli associated with novel coronavirus infection. The American journal of emergency medicine. 2020; 38(7): 1544. DOI: 10.1016/j.ajem.2020.04.011
22. Ran J, Song Y, Zhuang Z, Han L, Zhao S, Cao P, Geng Y, Xu L, Qin J and He D. Blood pressure control and adverse outcomes of COVID-19 infection in patients with concomitant hypertension in Wuhan, China. Hypertension Research. 2020; 43(11): 1267-76. https://doi.org/10.1038/s41440-020-00541-w
23. Hosseini A, Ghaleh HEG, Aghamollaei H, Ramandi MF, Alishiri G, Shahriary A, Hassanpour K, Tat M and Farnoosh G. Evaluation of Th1 and Th2 mediated cellular and humoral immunity in patients with COVID-19 following the use of melatonin as an adjunctive treatment. European Journal of Pharmacology. 2021; 904(174193). DOI: 10.1016/j.ejphar.2021.174193
24. Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, Bi Z and Zhao Y. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clinical Research in Cardiology. 2020; 109(5): 531-8. DOI: 10.1007/s00392-020-01626-9.
)